Task: Answer the multiple-choice question.
Question: Which drug exhibits a -60.558\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) CCN1CCN(c2nc(Nc3cccc(OC)c3)nc(N)c2[N+](=O)[O-])CC1
b) O=C(CSc1n[nH]c(-c2ccncc2)n1)Nc1ccc(Cl)cc1
Answer: a. CCN1CCN(c2nc(Nc3cccc(OC)c3)nc(N)c2[N+](=O)[O-])CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN1CCN(c2nc(Nc3cccc(OC)c3)nc(N)c2[N+](=O)[O-])CC1
CCN1CCN(c2nc(Nc3cccc(OC)c3)nc(N)c2[N+](=O)[O-])CC1
6-(4-ethylpiperazin-1-yl)-2-N-(3-methoxyphenyl)-5-nitropyrimidine-2,4-diamine